FAS and FAS Ligand Polymorphisms in the Promoter Regions and Risk of Gastric Cancer in Southern China

被引：29
|
作者：
Wang, Meilin [2 ]
Wu, Dongmei [2 ]
Tan, Ming [3 ]
Gong, Weida [4 ]
Xue, Hengchuan [4 ]
Shen, Hongbin [1 ]
Zhang, Zhengdong [1 ,2 ]
机构：
[1] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Stat, Nanjing, Peoples R China
[2] Nanjing Med Univ, Ctr Canc, Dept Mol & Genet Toxicol, Nanjing 210029, Peoples R China
[3] Yangzhong Canc Res Inst, Yangzhong, Jiangsu, Peoples R China
[4] Yixing Peoples Hosp, Yixing, Jiangsu, Peoples R China
来源：
BIOCHEMICAL GENETICS | 2009年 / 47卷 / 7-8期
基金：
中国国家自然科学基金;
关键词：
FAS; FAS ligand; Gastric cancer; Susceptibility; Molecular epidemiology; PATHWAY GENES FAS; FUNCTIONAL POLYMORPHISMS; HAPLOTYPE RECONSTRUCTION; BLADDER-CANCER; CELL-DEATH; APOPTOSIS; DISEQUILIBRIUM; EXPRESSION;
D O I：
10.1007/s10528-009-9264-0
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The FAS and FAS ligand (FASLG) system plays a key role in regulating apoptotic cell death, and corruption of this signaling pathway has been shown to participate in tumorigenesis. Functional promoter polymorphisms of the FAS and FASLG genes can alter transcriptional activities and thus alter risk of cancer. We hypothesized that the FAS -1377G > A, FAS -670A > G, and FASLG -844T > C polymorphisms in the promoter regions are associated with risk of gastric cancer. In a population-based case-control study of 332 gastric cancer cases and 324 controls, we genotyped these three polymorphisms and evaluated their association with risk of gastric cancer. We found that the FAS and FASL genotypes and the FAS haplotypes had no significant associations with risk of gastric cancer. In addition, there was no significant interaction between the FAS and FASL polymorphisms in the development of gastric cancer. The FAS and FASLG polymorphisms may not contribute to risk of gastric cancer in the southern Chinese population.
引用
收藏
页码：559 / 568
页数：10
相关论文
共 50 条
  • [31] Fas and Fas-ligand expression in human pancreatic cancer
    Kommann, M
    Ishiwata, T
    Kleeff, J
    Beger, HG
    Korc, M
    ANNALS OF SURGERY, 2000, 231 (03) : 368 - 379
  • [32] Is gastric ulceration associated with epithelial apoptosis mediated by Fas/Fas ligand system?
    Shimada, M
    Ina, K
    Ando, T
    Sakai, T
    Kusugami, K
    GUT, 1998, 43 : A19 - A19
  • [33] Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia
    Sibley, K
    Rollinson, S
    Allan, JM
    Smith, AG
    Law, GR
    Roddam, PL
    Skibola, CF
    Smith, MT
    Morgan, GJ
    CANCER RESEARCH, 2003, 63 (15) : 4327 - 4330
  • [34] Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck
    Zhang, Zhengdong
    Wang, Li-E
    Sturgis, Erich M.
    El-Naggar, Adel K.
    Hong, Waun K.
    Amos, Christopher I.
    Spitz, Margaret R.
    Wei, Qingyi
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5596 - 5602
  • [35] The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response
    Liu, Huanran
    Ubukata, Hideyuki
    Tabuchi, Takanobu
    Nakachi, Takeshi
    Nagata, Hiroyuki
    Shimazaki, Jiro
    Motohashi, Gyou
    Konishi, Satoru
    Nishimura, Motoi
    Satani, Tetsuro
    Hong, JianWei
    Nakada, Ichiro
    Saniabadi, Abbi R.
    Tabuchi, Takafumi
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 331 (1-2) : 181 - 186
  • [36] PLACENTAL CASPASE-3 BUT NOT FAS OR FAS LIGAND GENE POLYMORPHISMS IS ASSOCIATED WITH PREECLAMSIA
    Hsu, Chaur-Dong
    Polavarapu, Satya
    Maramreddy, Hima
    Parton, Lance
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : S209 - S209
  • [37] The relationship between Fas and Fas ligand gene polymorphism and preeclampsia risk
    Wang, Tingting
    Lian, Yunyun
    BIOSCIENCE REPORTS, 2019, 39
  • [38] The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response
    Huanran Liu
    Hideyuki Ubukata
    Takanobu Tabuchi
    Takeshi Nakachi
    Hiroyuki Nagata
    Jiro Shimazaki
    Gyou Motohashi
    Satoru Konishi
    Motoi Nishimura
    Tetsuro Satani
    JianWei Hong
    Ichiro Nakada
    Abbi R. Saniabadi
    Takafumi Tabuchi
    Molecular and Cellular Biochemistry, 2009, 331 : 181 - 186
  • [39] Association of the Polymorphisms in the Fas/FasL Promoter Regions with Cancer Susceptibility: A Systematic Review and Meta-Analysis of 52 Studies
    Xu, Yeqiong
    He, Bangshun
    Li, Rui
    Pan, Yuqin
    Gao, Tianyi
    Deng, Qiwen
    Sun, Huiling
    Song, Guoqi
    Wang, Shukui
    PLOS ONE, 2014, 9 (03):
  • [40] Polymorphisms in the promoter regions of FAS and FASL genes as candidate genetic factors conferring susceptibility to endometriosis
    Fernandez, RM
    Noval, JA
    Garcia-Lozano, JC
    Borrego, S
    Molini, JL
    Antiñolo, G
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 15 (05) : 865 - 869
12345